Overview
- At a White House briefing on autism, President Trump told pregnant women, “Don’t take it,” linked acetaminophen to a higher autism risk, and questioned pediatric vaccine schedules.
- Reporting indicates the FDA plans to revise acetaminophen labeling and notify clinicians, while the agency issued a more measured advisory noting no proven causality and conflicting studies.
- Recent research is mixed, with an August 2025 review suggesting an association, yet large cohort analyses, including a 2024 JAMA study of 2.5 million Swedish children, finding no link.
- Medical bodies continue to recommend acetaminophen as the preferred option for pain or fever in pregnancy when needed, noting that ibuprofen and aspirin are contraindicated late in pregnancy.
- The administration announced new funding, backed folinic acid use for certain autism cases, and elevated vaccine-skeptic voices in autism research, drawing warnings from experts about false hopes and public-health risks.